Qyuns Therapeutics Co., Ltd. (02509.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

4.8x

Market Cap

HKD 3.68B

MomentumView details →

1D Return

−1.73%

YTD Return

−12.46%

RSI (14)

46.5

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

4.8x

Market Cap

HKD 3.68B

RSI (14)

46.5

MomentumView details →

1D Return

−1.73%

YTD Return

−12.46%

ProfitabilityView details →

Gross Margin

88.64%

Net Margin

53.30%

EBITDA Margin

56.74%

ROE (TTM)

63.42%

ROA (TTM)

28.58%

Asset Turnover

0.54x

GrowthView details →

Revenue YoY

+219.81%

EPS YoY

+378.93%

FCF YoY

+341.75%

Revenue CAGR 3Y

+333.31%

EPS CAGR 3Y

+189.54%

EBITDA YoY

+471.01%

EarningsView details →

EPS (Actual)

HKD 1.05

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.80x

Current Ratio

2.29x

Quick Ratio

2.18x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

1.02B

Net Income (TTM)

546.10M

Op. CF (TTM)

519.90M

Next earningsMar 26, 2027 →

Latest newsMore news →

Caldera Therapeutics obtained commitments for a concurrent private placement of approximately $278 million from a syndicate of leading healthcare institutional investors and mutual funds to support the proposed merger.37d ago

Caldera Therapeutics entered into a definitive merger agreement for an all-stock merger with Synlogic, becoming wholly owned subsidiaries of a new holding company, and the combined company will operate as Caldera Therapeutics, Inc. and list on Nasdaq under ticker CALD.37d ago

Similar companies

AbCellera Biologics Inc.ABCL Mirxes Holding Company Limited02629.HK Arcus Biosciences, Inc.RCUS Shanghai Haohai Biological Technology Co., Ltd.06826.HK Amylyx Pharmaceuticals, Inc.AMLX Tango Therapeutics, Inc.TNGX Find similar companies →

Latest newsMore news →

Caldera Therapeutics obtained commitments for a concurrent private placement of approximately $278 million from a syndicate of leading healthcare institutional investors and mutual funds to support the proposed merger.37d ago Caldera Therapeutics entered into a definitive merger agreement for an all-stock merger with Synlogic, becoming wholly owned subsidiaries of a new holding company, and the combined company will operate as Caldera Therapeutics, Inc. and list on Nasdaq under ticker CALD.37d ago